Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1‐tube panel strategy for diagnosis and prognosis of patients with MDS
暂无分享,去创建一个
M. Fontenay | D. Bouscary | O. Kosmider | Charles Dussiau | Anne-Sophie Alary | N. Chapuis | Anna Raimbault | V. Bardet | S. Barreau | A. Green | S. Mathis | L. Willems
[1] A. A. van de Loosdrecht,et al. Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes , 2018, Pathobiology.
[2] B. Ebert,et al. Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions , 2017, Oncotarget.
[3] A. Órfão,et al. Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group , 2017, Haematologica.
[4] G. Ossenkoppele,et al. The myelodysplastic syndromes flow cytometric score: a three-parameter prognostic flow cytometric scoring system , 2016, Leukemia.
[5] F Lacombe,et al. Harmonemia: a universal strategy for flow cytometry immunophenotyping—A European LeukemiaNet WP10 study , 2016, Leukemia.
[6] P. M. van de Ven,et al. Regulatory T cells and progenitor B cells are independent prognostic predictors in lower risk myelodysplastic syndromes , 2015, Haematologica.
[7] T. Haferlach,et al. Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients , 2015, Cytometry. Part B, Clinical cytometry.
[8] M. Béné,et al. Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms , 2015, Haematologica.
[9] M. Loken,et al. Assessment of erythroid dysplasia by “Difference from normal” in routine clinical flow cytometry workup , 2014, Cytometry. Part B, Clinical cytometry.
[10] G. Ossenkoppele,et al. High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes , 2014, British journal of haematology.
[11] A Orfao,et al. Revisiting guidelines for integration of flow cytometry results in the WHO classification of myelodysplastic syndromes—proposal from the International/European LeukemiaNet Working Group for Flow Cytometry in MDS , 2014, Leukemia.
[12] F. Lacombe,et al. Comparable flow cytometry data can be obtained with two types of instruments, Canto II, and Navios. A GEIL study , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[13] M. Cazzola,et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. , 2013, Blood.
[14] M. Béné,et al. Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes , 2013, Leukemia.
[15] Luca Malcovati,et al. Revised international prognostic scoring system for myelodysplastic syndromes. , 2012, Blood.
[16] C. Pascutto,et al. Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study , 2012, Haematologica.
[17] A. Órfão,et al. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group , 2012, Leukemia.
[18] M. Loken,et al. Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes. , 2011, Leukemia research.
[19] J. Hernández-Rivas,et al. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: A pilot study on a series of 56 patients , 2010, Cytometry. Part B, Clinical cytometry.
[20] L. Malcovati,et al. Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study , 2009, Haematologica.
[21] A. Órfão,et al. Flow cytometry in myelodysplastic syndromes: report from a working conference. , 2008, Leukemia research.
[22] H. Deeg,et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. , 2003, Blood.
[23] M. Mori,et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. , 2002, Blood.
[24] C. Haanen,et al. A method for quantification of peripheral blood admixture in bone marrow aspirates. , 1980, Experimental hematology.